Theravance Biopharma (NASDAQ: TBPH)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Theravance Biopharma (NASDAQ: TBPH) through any online brokerage.
The latest price target for Theravance Biopharma (NASDAQ: TBPH) was reported by SVB Leerink on Monday, May 23, 2022. The analyst firm set a price target for 12.00 expecting TBPH to rise to within 12 months (a possible 36.67% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Theravance Biopharma (NASDAQ: TBPH) is $8.78 last updated Today at June 28, 2022, 7:24 PM UTC.
There are no upcoming dividends for Theravance Biopharma.
Theravance Biopharma’s Q2 earnings are confirmed for Tuesday, August 2, 2022.
There is no upcoming split for Theravance Biopharma.
Theravance Biopharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.